Literature DB >> 26973881

Glioblastoma-infiltrated innate immune cells resemble M0 macrophage phenotype.

Konrad Gabrusiewicz1, Benjamin Rodriguez2, Jun Wei1, Yuuri Hashimoto1, Luke M Healy3, Sourindra N Maiti4, Ginu Thomas5, Shouhao Zhou6, Qianghu Wang7, Ahmed Elakkad5, Brandon D Liebelt1, Nasser K Yaghi1, Ravesanker Ezhilarasan8, Neal Huang1, Jeffrey S Weinberg1, Sujit S Prabhu1, Ganesh Rao1, Raymond Sawaya1, Lauren A Langford9, Janet M Bruner9, Gregory N Fuller9, Amit Bar-Or3, Wei Li2, Rivka R Colen5, Michael A Curran10, Krishna P Bhat11, Jack P Antel3, Laurence J Cooper4, Erik P Sulman8, Amy B Heimberger1.   

Abstract

Glioblastomas are highly infiltrated by diverse immune cells, including microglia, macrophages, and myeloid-derived suppressor cells (MDSCs). Understanding the mechanisms by which glioblastoma-associated myeloid cells (GAMs) undergo metamorphosis into tumor-supportive cells, characterizing the heterogeneity of immune cell phenotypes within glioblastoma subtypes, and discovering new targets can help the design of new efficient immunotherapies. In this study, we performed a comprehensive battery of immune phenotyping, whole-genome microarray analysis, and microRNA expression profiling of GAMs with matched blood monocytes, healthy donor monocytes, normal brain microglia, nonpolarized M0 macrophages, and polarized M1, M2a, M2c macrophages. Glioblastoma patients had an elevated number of monocytes relative to healthy donors. Among CD11b+ cells, microglia and MDSCs constituted a higher percentage of GAMs than did macrophages. GAM profiling using flow cytometry studies revealed a continuum between the M1- and M2-like phenotype. Contrary to current dogma, GAMs exhibited distinct immunological functions, with the former aligned close to nonpolarized M0 macrophages.

Entities:  

Year:  2016        PMID: 26973881      PMCID: PMC4784261          DOI: 10.1172/jci.insight.85841

Source DB:  PubMed          Journal:  JCI Insight        ISSN: 2379-3708


  73 in total

1.  Tumor-infiltrating myeloid-derived suppressor cells are pleiotropic-inflamed monocytes/macrophages that bear M1- and M2-type characteristics.

Authors:  Naoki Umemura; Masanao Saio; Tatsuhiko Suwa; Yusuke Kitoh; Juncheng Bai; Kenichi Nonaka; Guan-Feng Ouyang; Makoto Okada; Margit Balazs; Roza Adany; Toshiyuki Shibata; Tsuyoshi Takami
Journal:  J Leukoc Biol       Date:  2008-02-19       Impact factor: 4.962

Review 2.  Physiology of microglia.

Authors:  Helmut Kettenmann; Uwe-Karsten Hanisch; Mami Noda; Alexei Verkhratsky
Journal:  Physiol Rev       Date:  2011-04       Impact factor: 37.312

3.  Distribution and characterization of microglia/macrophages in human brain tumors.

Authors:  W Roggendorf; S Strupp; W Paulus
Journal:  Acta Neuropathol       Date:  1996-09       Impact factor: 17.088

Review 4.  MicroRNA-mediated control of macrophages and its implications for cancer.

Authors:  Mario Leonardo Squadrito; Martin Etzrodt; Michele De Palma; Mikael J Pittet
Journal:  Trends Immunol       Date:  2013-03-13       Impact factor: 16.687

5.  Osteopontin regulates human glioma cell invasiveness and tumor growth in mice.

Authors:  Hsun-Jin Jan; Chin-Cheng Lee; Yung-Luen Shih; Dueng-Yuan Hueng; Hsin-I Ma; Jing-Huei Lai; Hen-Wei Wei; Horng-Mo Lee
Journal:  Neuro Oncol       Date:  2009-12-23       Impact factor: 12.300

6.  GM-CSF promotes the immunosuppressive activity of glioma-infiltrating myeloid cells through interleukin-4 receptor-α.

Authors:  Gary Kohanbash; Kayla McKaveney; Masashi Sakaki; Ryo Ueda; Arlan H Mintz; Nduka Amankulor; Mitsugu Fujita; John R Ohlfest; Hideho Okada
Journal:  Cancer Res       Date:  2013-09-12       Impact factor: 12.701

7.  Possible involvement of the M2 anti-inflammatory macrophage phenotype in growth of human gliomas.

Authors:  Y Komohara; K Ohnishi; J Kuratsu; M Takeya
Journal:  J Pathol       Date:  2008-09       Impact factor: 7.996

8.  Elevated neutrophil and monocyte counts in peripheral blood are associated with poor survival in patients with metastatic melanoma: a prognostic model.

Authors:  H Schmidt; L Bastholt; P Geertsen; I J Christensen; S Larsen; J Gehl; H von der Maase
Journal:  Br J Cancer       Date:  2005-08-08       Impact factor: 7.640

9.  Transcriptomic analysis of human polarized macrophages: more than one role of alternative activation?

Authors:  Eleonora Derlindati; Alessandra Dei Cas; Barbara Montanini; Valentina Spigoni; Valentina Curella; Raffaella Aldigeri; Diego Ardigò; Ivana Zavaroni; Riccardo C Bonadonna
Journal:  PLoS One       Date:  2015-03-23       Impact factor: 3.240

10.  Activated T cells sustain myeloid-derived suppressor cell-mediated immune suppression.

Authors:  Laura Pinton; Samantha Solito; Vera Damuzzo; Samuela Francescato; Assunta Pozzuoli; Antonio Berizzi; Simone Mocellin; Carlo Riccardo Rossi; Vincenzo Bronte; Susanna Mandruzzato
Journal:  Oncotarget       Date:  2016-01-12
View more
  169 in total

1.  Anti-PD-1 Induces M1 Polarization in the Glioma Microenvironment and Exerts Therapeutic Efficacy in the Absence of CD8 Cytotoxic T Cells.

Authors:  Ganesh Rao; Khatri Latha; Martina Ott; Aria Sabbagh; Anantha Marisetty; Xiaoyang Ling; Daniel Zamler; Tiffany A Doucette; Yuhui Yang; Ling-Yuan Kong; Jun Wei; Gregory N Fuller; Fernando Benavides; Adam M Sonabend; James Long; Shulin Li; Michael Curran; Amy B Heimberger
Journal:  Clin Cancer Res       Date:  2020-06-18       Impact factor: 12.531

Review 2.  PD-1 Inhibitors: Do they have a Future in the Treatment of Glioblastoma?

Authors:  Mustafa Khasraw; David A Reardon; Michael Weller; John H Sampson
Journal:  Clin Cancer Res       Date:  2020-06-11       Impact factor: 12.531

3.  Intravital 2-photon imaging reveals distinct morphology and infiltrative properties of glioblastoma-associated macrophages.

Authors:  Zhihong Chen; James L Ross; Dolores Hambardzumyan
Journal:  Proc Natl Acad Sci U S A       Date:  2019-06-24       Impact factor: 11.205

Review 4.  Genetic and molecular epidemiology of adult diffuse glioma.

Authors:  Annette M Molinaro; Jennie W Taylor; John K Wiencke; Margaret R Wrensch
Journal:  Nat Rev Neurol       Date:  2019-06-21       Impact factor: 42.937

Review 5.  Tumor-derived exosomes in the regulation of macrophage polarization.

Authors:  Mirza S Baig; Anjali Roy; Sajjan Rajpoot; Dongfang Liu; Rajkumar Savai; Sreeparna Banerjee; Manabu Kawada; Syed M Faisal; Rohit Saluja; Uzma Saqib; Tomokazu Ohishi; Kishore K Wary
Journal:  Inflamm Res       Date:  2020-03-11       Impact factor: 4.575

6.  Genetic driver mutations introduced in identical cell-of-origin in murine glioblastoma reveal distinct immune landscapes but similar response to checkpoint blockade.

Authors:  Zhihong Chen; Cameron J Herting; James L Ross; Ben Gabanic; Montse Puigdelloses Vallcorba; Frank Szulzewsky; Megan L Wojciechowicz; Patrick J Cimino; Ravesanker Ezhilarasan; Erik P Sulman; Mingyao Ying; Avi Ma'ayan; Renee D Read; Dolores Hambardzumyan
Journal:  Glia       Date:  2020-07-08       Impact factor: 7.452

Review 7.  Applications of Human Brain Organoids to Clinical Problems.

Authors:  H Isaac Chen; Hongjun Song; Guo-Li Ming
Journal:  Dev Dyn       Date:  2018-10-02       Impact factor: 3.780

8.  Tumor-derived microRNAs induce myeloid suppressor cells and predict immunotherapy resistance in melanoma.

Authors:  Veronica Huber; Viviana Vallacchi; Viktor Fleming; Xiaoying Hu; Agata Cova; Matteo Dugo; Eriomina Shahaj; Roberta Sulsenti; Elisabetta Vergani; Paola Filipazzi; Angela De Laurentiis; Luca Lalli; Lorenza Di Guardo; Roberto Patuzzo; Barbara Vergani; Elena Casiraghi; Mara Cossa; Ambra Gualeni; Valentina Bollati; Flavio Arienti; Filippo De Braud; Luigi Mariani; Antonello Villa; Peter Altevogt; Viktor Umansky; Monica Rodolfo; Licia Rivoltini
Journal:  J Clin Invest       Date:  2018-11-05       Impact factor: 14.808

Review 9.  The Role of Checkpoint Inhibitors in Glioblastoma.

Authors:  Kunal Desai; Anne Hubben; Manmeet Ahluwalia
Journal:  Target Oncol       Date:  2019-08       Impact factor: 4.493

10.  Brain tumor-initiating cells export tenascin-C associated with exosomes to suppress T cell activity.

Authors:  Reza Mirzaei; Susobhan Sarkar; Lauren Dzikowski; Khalil S Rawji; Lubaba Khan; Andreas Faissner; Pinaki Bose; V Wee Yong
Journal:  Oncoimmunology       Date:  2018-08-06       Impact factor: 8.110

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.